These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9292090)

  • 1. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
    Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
    J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag).
    Ghohestani R; Nicolas JF; Kanitakis J; Bedane C; Faure M; Claudy A
    Br J Dermatol; 1996 Mar; 134(3):603-4. PubMed ID: 8731696
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
    Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
    Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2.
    Ghohestani R; Kanitakis J; Nicolas JF; Cozzani E; Claudy A
    Br J Dermatol; 1996 Jul; 135(1):74-9. PubMed ID: 8776363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
    Seishima M; Izumi T; Kitajima Y
    Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens.
    Yoon KH; Kim SC; Kang DS; Lee IJ
    Eur J Dermatol; 2000; 10(3):212-4. PubMed ID: 10725820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
    Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
    Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N; Utecht L; James W; Yancey KB
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
    Hsu S; Ghohestani RF; Uitto J
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
    Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
    J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
    Korman NJ; Stanley JR; Woodley DT
    Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.